CClinicalTrials.gg
CompletedNCT00921141CCIUpdated Jul 23, 2012

Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports

An observational study in Cancer, sponsored by Centre Oscar Lambret. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-07-23.

Sponsored by Centre Oscar Lambret · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
815
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, descriptive and observational study of the anticancer center practice

02

Conditions studied

  • Cancer

Keywords

  • Implantable central venous access ports, cancer
03

In context

Lead sponsor

Centre Oscar Lambret is the lead sponsor of 127 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All the patients requiring the implementation of a catheter in an anticancerous center

Inclusion criteria

  • Patient with any cancer, requiring a central venous catheter
  • No contraindication for any surgery with local or complete anaesthesia

Exclusion criteria

Exclusion Criteria:

  • Previous Xylocaine or Lidocaine allergy
  • Clinic superior vena cava syndrome
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
815 participants (actual)

Groups and cohorts

  • study population

    Patient with cancer requiring a long-term central venous catheter

06

What researchers measure

Primary outcomes

  1. Incidence and collection of complications for the patients requiring an implantable central venous access ports substitution/change

    Time frame: Until the implantable central venous access ports removal

Secondary outcomes

  1. Brief description of the different risk factor for morbidity

    Time frame: Until the implantable central venous access ports removal

  2. Assessment of the implantable central venous access ports ease-of-use for nurses according to the modalities of implementation and patient features

    Time frame: Until the implantable central venous access ports removal

  3. Assessment of the patient quality of life

    Time frame: Before central venous access ports implementation, at the first day of chemotherapy, and during the cycle 4 of chemotherapy

07

Study locations

1 site
  • Centre Oscar Lambret
    Lille, 59020, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00921141
Lead sponsor
Centre Oscar Lambret
Responsible party
Sponsor
First posted
Jun 16, 2009
Start date
May 2006
Primary completion
Apr 2007
Completion
Apr 2009
Last update
Jul 23, 2012

Study contacts

Fabrice NARDUCCI, MD
principal investigator · Centre Oscar Lambret

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion